title: Influenza vaccination rates among pharmacists.
abstract: OBJECTIVE
  To quantify influenza vaccination rates and determine perceived barriers to influenza vaccination among U.S. pharmacists from various practice settings.
  
  
  METHODS
  Prospective study.
  
  
  METHODS
  United States in 2008.
  
  
  METHODS
  1,028 respondents, including 895 pharmacists.
  
  
  METHODS
  A survey request was distributed manually at the 2008 National Community Pharmacists Association annual meeting, and an initial e-mail was sent with two follow-up e-mails to all pharmacists who receive e-mails via Pharmacist e-link.
  
  
  METHODS
  Vaccination rates and barriers to vaccination among pharmacists.
  
  
  RESULTS
  Pharmacists reported an influenza vaccination rate of 78%, with coverage varying across practice settings: hospital (88%), academia (86%), clinic (83%), and community (75%). Employers infrequently required the influenza vaccine as a condition of employment (7%), and slightly more than one-half (58%) compensated pharmacists for being vaccinated; both of these were significantly associated with higher influenza vaccination rates (P < 0.001 for both). One-quarter of pharmacists (26%) expressed at least one issue regarding the influenza vaccine. Pharmacists were significantly less likely to be vaccinated if they expressed a concern (91% vs. 43%, P < 0.0001). Community pharmacists were significantly less likely to be compensated for receiving the influenza vaccination and significantly more likely to express one or more concerns than pharmacists from any other practice setting.
  
  
  CONCLUSIONS
  Pharmacists reported high influenza vaccination rates overall, with slight variability among practice settings. Although employers infrequently required influenza vaccination, approximately one-half of employers compensated their pharmacists for being vaccinated. Employer incentives and pharmacist attitudes were highly correlated with influenza vaccination.
authors.affiliation: College of Pharmacy, University of Texas, Austin, USA.
authors.forename: Andres D
authors.initials: AD
authors.lastname: Ruiz
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Frei
authors.forename: Jamie C
authors.initials: JC
authors.lastname: Barner
authors.forename: John J
authors.initials: JJ
authors.lastname: Carson
authors.forename: Christine U
authors.initials: CU
authors.lastname: Oramasionwu
authors.forename: Jessica L
authors.initials: JL
authors.lastname: Ruiz
authors.forename: Kelly R
authors.initials: KR
authors.lastname: Daniels
authors.forename: John F
authors.initials: JF
authors.lastname: Mohr
authors.forename: Michael E
authors.initials: ME
authors.lastname: Klepser
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001291:Attitude of Health Personnel; D019538:Health Care Surveys; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007251:Influenza, Human / Q000517:prevention & control*; D008875:Middle Aged; D010595:Pharmacists / Q000523:psychology* / Q000706:statistics & numerical data*; D014481:United States; D014611:Vaccination / Q000523:psychology / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D007252:Influenza Vaccines